The Health for Life in Singapore (HELIOS) Study is a state-of-the-art population cohort study, established and led by Lee Kong Chian School of Medicine, in partnership with National Healthcare Group and Imperial College London. Our population study aims to identify environmental, lifestyle and genetic factors that cause heart disease, diabetes, cancer and other chronic diseases in Singapore.
We are studying 10,000 Singaporeans or Permanent Residents aged 30-84 years old from all walks of life, including people with pre-existing health conditions. Our ultimate goal is to develop innovative and effective approaches for prediction, prevention and control of chronic diseases. By doing this, we aim to improve the health and lives of generations of Singaporeans to come.
The HELIOS study will provide a powerful resource for medical research across a wide range of disciplines that will be accessible to biomedical researchers worldwide.
We are studying 10,000 Singaporeans or Permanent Residents aged 30-84 years old from all walks of life, including people with pre-existing health conditions. Our ultimate goal is to develop innovative and effective approaches for prediction, prevention and control of chronic diseases. By doing this, we aim to improve the health and lives of generations of Singaporeans to come.
The HELIOS study will provide a powerful resource for medical research across a wide range of disciplines that will be accessible to biomedical researchers worldwide.
VISION AND MISSION
The unique and extensive measurements and samples collected, together with long term follow-up will enable the investigation of the complex interrelationships between environmental, lifestyle and genetic factors on subsequent disease risk. The HELIOS study will thus provide a powerful resource for medical research across a wide range of disciplines for both the current and future generations of biomedical researchers.
- Prof. John Chambers
STUDY PARTNERS & COLLABORATORS
PRINCIPAL INVESTIGATORS
